Related Articles
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: An EORTC Receptor and Biomarker Group collaboration
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion
Immunolocalization of the components of the plasminogen activating system in breast carcinoma tissue
Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance
Tissue urokinase-type plasminogen activator receptor levels in breast cancer.